Close

Heron Therapeutics (HRTX) Reports Q3 Loss of $1.24/Share

November 8, 2016 4:02 PM EST

Heron Therapeutics (NASDAQ: HRTX) reported Q3 EPS of ($1.24), versus ($0.63) reported last year.

For earnings history and earnings-related data on Heron Therapeutics (HRTX) click here.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Earnings

Related Entities

Earnings